Skip to main content
Haisco Pharmaceutical Group Co.,Ltd logo

Haisco Pharmaceutical Group Co.,Ltd — Investor Relations & Filings

Ticker · 002653 ISIN · CNE100001BC7 LEI · 300300GRLH34A8GPJ639 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,439 across all filing types
Latest filing 2023-08-31 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 002653

About Haisco Pharmaceutical Group Co.,Ltd

https://www.haisco.com

Haisco Pharmaceutical Group Co.,Ltd. focuses on the research, development, production, and commercialization of innovative drugs and high-end generic pharmaceuticals. The company maintains a specialized portfolio across therapeutic areas including anesthesia, parenteral nutrition, anti-infection, cardiovascular health, and endocrine disorders. Key products include advanced anesthetic agents and specialized nutritional injections designed for clinical use. Haisco prioritizes technological innovation through a dedicated R&D infrastructure, targeting the development of small molecule chemical drugs and complex delivery systems. Its operations emphasize high-standard manufacturing processes and the integration of clinical research to address complex medical requirements. The company aims to provide therapeutic solutions that enhance patient care through a commitment to scientific excellence and product quality.

Recent filings

Filing Released Lang Actions
关于对控股子公司减资暨关联交易的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the progress of a capital reduction by a controlling subsidiary and related party transaction. It includes details about board and shareholder approvals, transaction completion, and references a previous announcement. The document is short (826 characters) and serves as an update on a specific corporate action rather than a full financial report or detailed management discussion. It does not contain financial statements or comprehensive financial data. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes.
2023-08-31 Chinese
关于收购控股子公司股权的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the acquisition of 100% equity of a subsidiary company by the listed company. It details the transaction overview, parties involved, financial data of the target company, transaction terms, and the impact on the listed company. It includes audited financial figures but does not contain comprehensive financial statements or a full financial report. The document is a formal announcement of a capital transaction (equity acquisition) rather than a full financial report or earnings release. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length is about 4,000 characters, which is consistent with an announcement rather than a full report.
2023-08-31 Chinese
关于选举职工代表监事的公告
Board/Management Information Classification · 95% confidence The document is an announcement regarding the election of an employee representative supervisor (监事) at the company Hai Si Ke Pharmaceutical Group Co., Ltd. It details the election process, qualifications, and the term of the newly elected supervisor. There is no financial data, no mention of financial results, no regulatory filings or certifications, and no reference to annual or interim reports. The document is a formal announcement about a board/management related change, specifically about the supervisory board composition. Therefore, it fits best under the category of Board/Management Information (MANG). The document length is short and it is not a report publication announcement or a certification, so those categories are excluded.
2023-08-31 Chinese
第五届监事会第一次会议决议公告
Board/Management Information Classification · 95% confidence The document is an announcement of the resolution from the first meeting of the fifth Supervisory Board of the company, including the election of the Supervisory Board Chairman. It contains no financial data, no financial statements, and no mention of annual or interim reports. It is a formal announcement related to board/management changes, specifically the election of a supervisory board chairman. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and it is not a report publication or certification. Hence, the classification is MANG with high confidence.
2023-08-31 Chinese
第五届董事会第一次会议决议公告
Board/Management Information Classification · 100% confidence The document is a detailed announcement of the resolutions passed at the first meeting of the fifth board of directors of Haisco Pharmaceutical Group Co., Ltd. It includes election and appointment of the chairman, board committees, general manager, deputy general managers, board secretary, financial director, and securities affairs representative. It also mentions approval of a subsidiary acquisition. The document contains biographies of the appointed individuals and compliance statements. There is no financial data or quarterly/yearly report content. The focus is on board and senior management appointments and changes. Therefore, this document fits the category of Board/Management Information (MANG). The document length (6159 characters) and content confirm it is not a brief announcement or a report publication notice but a substantive management information disclosure.
2023-08-31 Chinese
北京市中伦（深圳）律师事务所关于海思科医药集团股份有限公司2023年第二次临时股东大会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the procedural legality and validity of a company's 2023 second extraordinary general meeting of shareholders. It details the convening, attendance, voting procedures, and results of the meeting. The document does not contain financial statements or performance data, nor is it a report of financial results or management discussion. It is not a report publication announcement but a legal opinion on the shareholder meeting process and voting outcomes. This type of document fits best under Declaration of Voting Results & Voting Rights Announcements (DVA), as it relates to official voting results and meeting procedures.
2023-08-25 Chinese

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.